Conex (Llorens Pharmaceutical International Division)


Welcome to the PulseAid listing for the Conex drug offered from Llorens Pharmaceutical International Division. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Llorens Pharmaceutical International Division
NON-PROPRIETARY NAME: Dexbrompheniramine Maleate, Pseudoephedrine
SUBSTANCE NAME: DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00


Conex HUMAN OTC DRUG Details:

Item DescriptionConex from Llorens Pharmaceutical International Division
LABELER NAME: Llorens Pharmaceutical International Division
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 30(mg/5mL; mg/5mL)
START MARKETING DATE: 2007-11-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54859-802_81585939-78ee-4df2-8f65-429b017621c7
PRODUCT NDC: 54859-802
APPLICATION NUMBER: part341

Other DEXBROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ACTIPHARMA, INCACTICON
Actipharma, IncACTICON
Advanced Generic CorporationBIO-CNEX
Llorens Pharmaceutical International DivisionConex
LLORENS PHARMACEUTICALS INTERNATIONAL DIVISIONConex
McLaren MedicalG-Con-X